miR-150 represses metastasis of hepatocellular carcinoma by targeting HMGA2

被引:0
作者
Liu, Xiaoying [1 ]
Liu, Yuan [1 ]
Ye, Suiyan [1 ]
Gong, Yanwei [1 ]
Fan, Haiyan [1 ]
Miao, Lingli [2 ]
机构
[1] Yanan Univ, Affiliated Hosp 2, Hosp Yulin 1, Dept Clin Lab, Yulin 718000, Shaanxi, Peoples R China
[2] Fourth Hosp Yulin, Dept Clin Lab, 33 Western People Rd, Yulin 719000, Shaanxi, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 07期
关键词
miR-150; HMGA2; hepatocellular carcinoma; migration; invasion; MOBILITY-GROUP A2; CELL-PROLIFERATION; POOR-PROGNOSIS; CANCER; EXPRESSION; GROWTH;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
MicroRNAs (miRNAs) play critical roles in carcinogenesis and tumor progression. However, the mechanism of miR-150 funcions as a tumor suppressor or oncogene remains controversial. In this study, we found that miR-150 was significantly increased in hepatocellular carcinoma (HCC) tissues and cell lines. Overexpression of miR-150 suppressed HCC cell metastatic ability. miR-150 was a negative regulator of HMGA2 by directly combining with the 3'-UTR, and overexpression of miR-150 significantly inhibited the mRNA and protein expression levels of HMGA2. In addition, si-HMGA2 could partially attenuate the pro-oncogenic effects of anti-miR-150 on HCC cells. HMGA2 was inversely correlated with miR-150 in HCC tissues. Taken together, these results suggested that miR-150 inhibited HCC metastasis by targeting HMGA2 and might be used as a therapeutic target for the development of novel HCC treatment.
引用
收藏
页码:13836 / 13843
页数:8
相关论文
共 15 条
  • [1] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2
    Chen, Zhijun
    Li, Qingwen
    Wang, Sheng
    Zhang, Jiajun
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (04) : 1136 - 1142
  • [4] MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1
    Dou, Changwei
    Wang, Yufeng
    Li, Chao
    Liu, Zhikui
    Jia, Yuli
    Li, Qing
    Yang, Wei
    Yao, Yingmin
    Liu, Qingguang
    Tu, Kangsheng
    [J]. ONCOTARGET, 2015, 6 (15) : 13216 - 13228
  • [5] miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb
    Feng, Junlan
    Yang, Yongzhi
    Zhang, Peng
    Wang, Feng
    Ma, Yanlei
    Qin, Huanlong
    Wang, Yu
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (10) : 2125 - 2134
  • [6] HMG chromosomal proteins in development and disease
    Hock, Robert
    Furusawa, Takashi
    Ueda, Tetsuya
    Bustin, Michael
    [J]. TRENDS IN CELL BIOLOGY, 2007, 17 (02) : 72 - 79
  • [7] miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma
    Kim, Tae Hoen
    Song, Ji-ye
    Park, Hyun
    Jeong, Ju-yeon
    Kwon, A-young
    Heo, Jin Hyung
    Kang, Haeyoun
    Kim, Gwangil
    An, Hee Jung
    [J]. CANCER LETTERS, 2015, 356 (02) : 937 - 945
  • [8] High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition
    Lee, Junhyun
    Ha, Shinjung
    Jung, Chan-Kwon
    Lee, Han Hong
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (06) : 2431 - 2438
  • [9] miR-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14
    Li, Tao
    Xie, Junjie
    Shen, Chuan
    Cheng, Dongfeng
    Shi, Yuan
    Wu, Zhichong
    Zhan, Qian
    Deng, Xiaxing
    Chen, Hao
    Shen, Baiyong
    Peng, Chenghong
    Li, Hongwei
    Zhu, Zhecheng
    [J]. PLOS ONE, 2014, 9 (12):
  • [10] TREATMENT OPTIONS IN HEPATOCELLULAR CARCINOMA TODAY
    Livraghi, T.
    Makisalo, H.
    Line, P. -D.
    [J]. SCANDINAVIAN JOURNAL OF SURGERY, 2011, 100 (01) : 22 - 29